Hologic/Grifols, Roche Molecular Zika Tests Tapped For Blood-Screening Ramp-Up
Executive Summary
A blood-screening test made by Hologic in collaboration with Grifols, and another made by Roche Molecular Diagnostics, are being used in a gradual ramp-up of Zika virus screening at blood donation centers across the US under a new FDA program.
You may also be interested in...
FDA Approves Roche Molecular Cobas Test As Zika Virus Blood Donor Screen
US FDA approved Roche Molecular Diagnostics' cobas Zika virus test to screen plasma specimens from blood and organ donors.
Blood Brothers No More: Hologic Unloads Blood-Screening Business To Partner Grifols
Hologic's partner in the blood-screening business, Grifols SA, will buy-out Hologic's share for $1.85bn. Grifols already owns all the customer-facing parts of the business; it will now take on research, development and manufacture of assays and instruments based on nucleic acid testing for transfusion and transplantation screening.
Short-Term US Funding Bill Passes With $1.1bn In Emergency Zika Funds
Congress managed to settle its disputes over funding riders Sept. 28 and passed a relatively clean bill that contains $1.1bn in emergency Zika virus response funding, and will keep government agencies – including US FDA – running at current spending levels until Dec. 9.